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Introduction
The rise of multidrug resistant (MDR) pathogens is 
one of the greatest medical concerns of the century 
because the use of antibiotics in these infections is 
almost entirely useless, leaving patients at a higher 
risk of mortality. In addition, almost 80% of human 
infections involve biofilms which can be up to 1000-
fold more resistant to antibiotics than planktonic 
cells, such as the biofilm-associated cells of 
Pseudomonas aeruginosa. The resistance of these 
pathogens has initiated an urgent need to look for 
alternative antimicrobial therapies such as phage 
therapy. In Phage therapy, lytic bacteriophages 
eliminate bacteria that cause infection, even those 
caused my MDR pathogens. Our lab has examined a 
successful combinational therapy that treats biofilms 
of P. aeruginosa using a lytic bacteriophage (PEV2) 
and our novel patented porphyrin (ZnPor).
Results
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Discussion
• While ZnPor retains significant dark 
toxicity, photoactivation of ZnPor has 
complete viricidal activity.
• Obligately lytic bacteriophage PEV2 has 
significant bactericidal activity against 
Pseudomonas aeruginosa.
• There is a significant synergistic effect 
against P. aeruginosa biofilms when ZnPor 
is used in combination with PEV2 that can 
be seen quantitatively & qualitatively 
(confocal laser scanning microscopy).
• The significance of the combination 
therapy is increased when photoactivated. 
• Phage PEV2 can be eliminated from the 
system when in the presence of ZnPor and 
can be completely eradicated off of 
Titanium and Hydroxyapatite when ZnPor 
is photoactivated.
Methods
Figure 1: Phage subjected to ZnPor (25µM) in the presence of light 
(300W) showed complete and immediate viricidal activity. Phage 
subjected to ZnPor (25µM) without the presence of light still 
showed a significant decrease from the control. (** > 2 log 
difference of respective control, ***> 3 log difference of respective 
control)
Figure 2: Planktonic PAO1 is completely lysed by PEV2 (MOI 
10:1)  at 4 hours. (** > 2 log difference respective of control, 
***> 3 log difference respective of control)
Figure 3: Biofilms grown and subjected to a combination 
treatment consisting of ZnPor (25µM) and phage PEV2 (MOI 
10:1) then treated for 20 mins with and without light. on (A) 
Polyethylene (Found in catheters and other plastics) (B) Titanium 
(Found in biomedical implants) (C) Hydroxyapatite substrata 
(Alternative to bone)
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Figure 4: Phage quantifications after combination 
treatment residing on coupons of (A) Polyethylene (B) 
Titanium (C) Hydroxyapatite substrata (significance 
determined by comparison to relative control)
Figure 5: Confocal laser scanning microscopy of biofilms on selected 
substrata imaged using a LIVE/DEAD stain. Green=LIVE, Red=DEAD, 
Blue=ZnPor localization, Purple=overlap of ZnPor and Dead stains
Significance
The significance of our novel approach of antimicrobial 
management is that, unlike other protocols involving 
biofilm eradication, our strategy addresses the issue of 
resistance. 
